Trials / Sponsors / Karo Bio AB
Karo Bio AB
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Efficacy and Safety Study of Eprotirome in HeFH Patients Who Are on Optimal Standard of Care Heterozygous Familial Hypercholesterolaemia | Phase 3 | 2011-10-01 |
| Completed | LDL-Cholesterol Lowering Effect of KB2115 as Add on to Ezetimibe Hypercholesterolemia | Phase 2 | 2008-04-01 |
| Completed | LDL-Cholesterol Lowering Effect of KB2115 as Add on to Statin Dyslipidemia | Phase 2 | 2007-11-01 |
| Completed | Eprotirome for the Treatment of Dyslipidemia, Efficacy and Safety 12-Week, Phase ii Study to Assess the Safety Primary Hypercholesterolemia | Phase 2 | 2006-09-01 |